Thus, in addition to aspartate conservation, ccRCC tumors likely reduce ASS1 and ASL expression to curb NO generation and circumvent its cell-intrinsic anti-proliferative effects. The gene discussed is ASS1; the disease is nonpapillary renal cell carcinoma.